The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Alginic Acid-Coated Chitosan Nanoparticles Loaded with Legumain DNA Vaccine: Effect against Breast Cancer in Mice
Open accessAbstract
Legumain-based DNA vaccines have potential to protect against breast cancer. However, the lack of a safe and efficient oral delivery system restricts its clinical application. Here, we constructed alginic acid-coated chitosan nanoparticles (A.C.NPs) as an oral delivery carrier for a legumain DNA vaccine. First, we tested its characteristic in acidic environments in vitro. DNA agarose electrophoresis data show that A.C.NPs protected DNA better from degradation in acidic solution (pH 1.5) than did chitosan nanoparticles (C.NPs). Furthermore, size distribution analysis showed that A.C.NPs tended to aggregate and form micrometer scale complexes in pH<2.7, while dispersing into nanoparticles with an increase in pH. Mice were intragastrically administrated A.C.NPs carrying EGFP plasmids and EGFP expression was detected in the intestinal Peyer's patches. Full-length legumain plasmids were loaded into different delivery carriers, including C.NPs, attenuated Salmonella typhimurium and A.C.NPs. A.C.NPs loaded with empty plasmids served as a control. Oral vaccination was performed in the murine orthotopic 4T1 breast cancer model. Our data indicate that tumor volume was significantly smaller in groups using A.C.NPs or attenuated Salmonella typhimurium as carriers. Furthermore, splenocytes co-cultured them with 4T1 cells pre-stimulated with CoCl2, which influenced the translocation of legumain from cytoplasm to plasma membrane, showed a 4.7 and 2.3 folds increase in active cytotoxic T lymphocytes (CD3(+)/CD8(+)/CD25(+)) when treated with A.C.NPs carriers compared with PBS C.NPs. Our study suggests that C.NPs coated with alginic acid may be a safe and efficient tool for oral delivery of a DNA vaccine. Moreover, a legumain DNA vaccine delivered orally with A.C.NPs can effectively improve autoimmune response and protect against breast cancer in mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It was shown that this vaccine could effectively improve autoimmune response and protect against breast cancer in mice [91].”
From Anticancer and Cancer Preventive Properties of Marine Polysaccharides: Some Results and Prospects (2013) · cites this paper as [91]
In the citing paper
“Alginic acid-coated chitosan nanoparticles have been constructed as an oral delivery carrier for the legumain-based DNA vaccine.”
From Anticancer and Cancer Preventive Properties of Marine Polysaccharides: Some Results and Prospects (2013) · cites this paper as [91]
In the citing paper
“Polysaccharides isolated from various microalgae ranging from diatoms to green-blue algae demonstrated different activities, although direct anticancer properties were rarely reported [91].”
From Anticancer and Cancer Preventive Properties of Marine Polysaccharides: Some Results and Prospects (2013) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Implantable applications of chitin and chitosan
Khor, E., & Lim, L. Y. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00026-7 · Cited by 1,672
Roy, K., Mao, H., Huang, S.-K., & Leong, K. (1999) · Nature Medicine · doi:10.1038/7385 · Cited by 1,114
Biologically erodable microspheres as potential oral drug delivery systems
Mathiowitz, E., Jacob, J. S., Jong, Y. S., Carino, G. P., Chickering, D. E., Chaturvedi, P., Santos, C. A., Vijayaraghavan, K., Montgomery, S., Bassett, M., et al. (1997) · Nature · doi:10.1038/386410a0 · Cited by 823
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
Yang, Z.-Y., Kong, W., Huang, Y., Roberts, A., Murphy, B., Subbarao, K., & Nabel, G. (2004) · Nature · doi:10.1038/nature02463 · Cited by 688
Targeting tumor-associated macrophages as a novel strategy against breast cancer
Luo, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27648 · Cited by 551
Yin, L., Ding, J., He, C., Cui, L., Tang, C., & Yin, C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.06.055 · Cited by 451
Chitosan nanoparticles for oral drug and gene delivery
Bowman, K., & Leong, K. W. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.2.117 · Cited by 448
A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth
Niethammer, A. G., Xiang, R., Becker, J. C., Wodrich, H., Pertl, U., Karsten, G., Eliceiri, B. P., & Reisfeld, R. A. (2002) · Nature Medicine · doi:10.1038/nm1202-794 · Cited by 400
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Borges O, Cordeiro-da-Silva A, Romeijn SG, Amidi M, de Sousa A, <etal>et al</etal>.. (2006) Uptake studies in rat Peyer’s patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination. J Control Release 114: 348–358. Epub 2006 Jun 2016. · DOI
Cited by
Sorted by citations
Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration
Zhou, Z., Liu, X., Zhu, D., Wang, Y., Zhang, Z., Zhou, X., Qiu, N., Chen, X., & Shen, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.021 · Cited by 387
Self-citation“The Good, the Bad and the Ugly” of Chitosans
Bellich, B., D’Agostino, I., Semeraro, S., Gamini, A., & Cesàro, A. (2016) · Marine Drugs · doi:10.3390/md14050099 · Cited by 389
Biomaterials for Nanoparticle Vaccine Delivery Systems
Sahdev, P., Ochyl, L. J., & Moon, J. J. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1419-y · Cited by 308
Structure and function of legumain in health and disease
Dall, E., & Brandstetter, H. (2015) · Biochimie · doi:10.1016/j.biochi.2015.09.022 · Cited by 289
Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy
Fan, Y., & Moon, J. J. (2015) · Vaccines · doi:10.3390/vaccines3030662 · Cited by 278
Siafaka, P. I., Okur, N. Ü., Karavas, E., & Bikiaris, D. Ν. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091440 · Cited by 224
Tumor-Associated Macrophages as Target for Antitumor Therapy
Sawa-Wejksza, K., & Kandefer‐Szerszeń, M. (2017) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-017-0480-8 · Cited by 207
Anticancer and Cancer Preventive Properties of Marine Polysaccharides: Some Results and Prospects
Fedorov, S., Ermakova, S., Zvyagintseva, T., & Stonik, V. (2013) · Marine Drugs · doi:10.3390/md11124876 · Cited by 189
Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment
Liu, Z., Xiong, M., Gong, J., Zhang, Y., Bai, N., Luo, Y., Li, L., Wei, Y., Liu, Y., Tan, X., et al. (2014) · Nature Communications · doi:10.1038/ncomms5280 · Cited by 186
Self-citationWang, X., Chen, Y., Dahmani, F. Z., Yin, L., Zhou, J., & Yao, J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.053 · Cited by 162
Oral delivery of nanoparticle-based vaccines
Marasini, N., Skwarczyński, M., & Tóth, I. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.936852 · Cited by 157
Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy
Babu, A., & Ramesh, R. (2017) · Marine Drugs · doi:10.3390/md15040096 · Cited by 154
Biomedical Nanoparticles: Overview of Their Surface Immune-Compatibility
Gamucci, O., Bertero, A., Gagliardi, M., & Bardi, G. (2014) · Coatings · doi:10.3390/coatings4010139 · Cited by 137
Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments
Cuzzubbo, S., Mangsbo, S. M., Nagarajan, D., Habra, K., Pockley, A. G., & McArdle, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.615240 · Cited by 131
Theranostic nanoparticles with disease-specific administration strategies
Zhang, P., Li, Y., Tang, W., Zhao, J., Jing, L., & McHugh, K. J. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101335 · Cited by 120
Biswas, S., Chattopadhyay, M., Sen, K. K., & Saha, M. K. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.12.044 · Cited by 109
How successful is nuclear targeting by nanocarriers?
Tammam, S. N., Azzazy, H. M. E.-S., & Lamprecht, A. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.03.022 · Cited by 108
Nano and Microparticles as Potential Oral Vaccine Carriers and Adjuvants Against Infectious Diseases
Jazayeri, S. D., Lim, H. X., Shameli, K., Yeap, S. K., & Poh, C. L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.682286 · Cited by 100
Chemical Modification of Chitosan for Efficient Vaccine Delivery
Xing, L., Fan, Y., Zhou, T., Gong, J., Cui, L.-H., Cho, K., Choi, Y., Jiang, H., & Cho, C. (2018) · Molecules · doi:10.3390/molecules23020229 · Cited by 94
Self-citationPathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale
Rosenthal, J. A., Chen, L., Baker, J. L., Putnam, D. A., & DeLisa, M. P. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.11.005 · Cited by 95
Polymer nanotechnology based approaches in mucosal vaccine delivery: Challenges and opportunities
Sharma, R. K., Agrawal, U., Mody, N., & Vyas, S. P. (2014) · Biotechnology Advances · doi:10.1016/j.biotechadv.2014.12.004 · Cited by 91
Micro- and nanoparticulates for DNA vaccine delivery
Farris, E., Brown, D. M., Ramer‐Tait, A. E., & Pannier, A. K. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216643771 · Cited by 88
Song, X., Wan, Z., Chen, T., Fu, Y. S., Jiang, K., Yi, X., Ke, H., Dong, J., Yang, L., Li, L., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.09.001 · Cited by 82
Natural and semisynthetic polymers in pharmaceutical nanotechnology
Dmour, I. M., & Taha, M. O. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813663-8.00002-6 · Cited by 82
Chitosan: A versatile bio-platform for breast cancer theranostics
Madamsetty, V. S., Tavakol, S., Moghassemi, S., Dadashzadeh, A., Schneible, J. D., Fatemi, I., Shirvani, A., Zarrabi, A., Azedi, F., Dehshahri, A., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.12.012 · Cited by 74
Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches
Davodabadi, F., Sarhadi, M., Arabpour, J., Sargazi, S., Rahdar, A., & Diez-Pascual, A. M. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.07.036 · Cited by 75
Insulin-loaded alginic acid nanoparticles for sublingual delivery
Patil, N. H., & Devarajan, P. V. (2014) · Drug Delivery · doi:10.3109/10717544.2014.916769 · Cited by 73
Zhen, Y., Guo, C., Wenzhi, S., Zhao, S., Luo, N., Rongrong, W., Luo, X., Niu, H., Dehong, L., Shan, J., et al. (2015) · Scientific Reports · doi:10.1038/srep16599 · Cited by 73
Self-citationEngineered polysaccharides for controlling innate and adaptive immune responses
Nam, J., Kim, A., Kim, K. H., Moon, J. H., Baig, J., Phoo, M. T., Moon, J. J., & Son, S. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00193-2 · Cited by 76
Rafiee, A., Alimohammadian, M. H., Gazori, T., Riazi‐Rad, F., Fatemi, S. M. R., Parizadeh, A., Haririan, I., & Havaskary, M. (2014) · Asian Pacific Journal of Tropical Disease · doi:10.1016/s2222-1808(14)60590-9 · Cited by 68
Biopolymer‐based Carriers for DNA Vaccine Design
Franck, C. O., Fanslau, L., Bistrović, A., Tyagi, P., & Fruk, L. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202010282 · Cited by 63
Polymers for DNA Vaccine Delivery
Zhang, M., Hong, Y., Chen, W., & Wang, C. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00418 · Cited by 61
Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes
Dosekova, E., Filip, J., Bertók, T., Both, P., Kasák, P., & Tkáč, J. (2016) · Medicinal Research Reviews · doi:10.1002/med.21420 · Cited by 61
Chellappan, D. K., Yee, N. J., Singh, B. J. A. J., Panneerselvam, J., Madheswaran, T., Chellian, J., Satija, S., Mehta, M., Gulati, M., Gupta, G., et al. (2019) · Therapeutic Delivery · doi:10.4155/tde-2019-0019 · Cited by 54
Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy
Chen, Z., Yue, Z., Yang, K., Shen, C., Cheng, Z., Zhou, X., & Li, S. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300882 · Cited by 53
Lima, B. V., Oliveira, M. J., Barbosa, M. A., Gonçalves, R. M., & Castro, F. (2021) · Biomaterials Science · doi:10.1039/d0bm01984d · Cited by 51
Advances in Chitosan-Based CRISPR/Cas9 Delivery Systems
Caprifico, A. E., Foot, P. J. S., Polycarpou, E., & Calabrese, G. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091840 · Cited by 50
Immunology‐Guided Biomaterial Design for Mucosal Cancer Vaccines
Ferber, S., Gonzalez, R. J., Cryer, A. M., von Andrian, U. H., & Artzi, N. (2019) · Advanced Materials · doi:10.1002/adma.201903847 · Cited by 49
An Overview of Nanomaterial Applications in Pharmacology
Roy, M., Roy, A., Rustagi, S., & Pandey, N. (2023) · BioMed Research International · doi:10.1155/2023/4838043 · Cited by 51
Nanotechnology-enabled immunoengineering approaches to advance therapeutic applications
Chuang, S. T., Conklin, B., Stein, J. B., Pan, G., & Lee, K. (2022) · Nano Convergence · doi:10.1186/s40580-022-00310-0 · Cited by 48
Plausible role of chitosan in drug and gene delivery against resistant breast cancer cells
Nandgude, T. D., & Pagar, R. R. (2021) · Carbohydrate Research · doi:10.1016/j.carres.2021.108357 · Cited by 48
Role of LGMN in tumor development and its progression and connection with the tumor microenvironment
Khan, S. U., Khan, I. M., Khan, M. U., Din, M. A. U., Khan, M. Z., Khan, N. M., & Liu, Y. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1121964 · Cited by 46
Lybaert, L., Vermaelen, K. Y., Geest, B. G. D., & Nuhn, L. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.09.009 · Cited by 46
Effect of xanthohumol on Th1/Th2 balance in a breast cancer mouse model
Zhang, W., Pan, Y., Gou, P., Zhou, C., Ma, L., Liu, Q., Du, Y., Yang, J., & Wang, Q. (2017) · Oncology Reports · doi:10.3892/or.2017.6094 · Cited by 44
Cancer immunotherapy: a promising dawn in cancer research.
Bondhopadhyay, B., Sisodiya, S., Chikara, A., Khan, A., Tanwar, P., Afroze, D., Singh, N., Agrawal, U., Mehrotra, R., & Hussain, S. (2020) · Europe PMC (PubMed Central) · Cited by 41
Yu, Z., Zhang, X., Pei, X., Cao, W., Ye, J., Wang, J., Sun, L., Yu, F., Wang, J., Li, N., et al. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120940 · Cited by 40
Kaikabo, A. A., Mohammed, A. S., & Abas, F. (2016) · Molecules · doi:10.3390/molecules21030256 · Cited by 37
Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review
Koyande, N. P., Srivastava, R., Padmakumar, A., & Rengan, A. K. (2022) · Vaccines · doi:10.3390/vaccines10101727 · Cited by 32
Non-invasive administration of biodegradable nano-carrier vaccines.
Kalam, M. A., Khan, A. A., & Alshamsan, A. (2017) · PubMed Central · Cited by 28
Recent advances in the development of breast cancer vaccines
Valabrega, G., Milani, A., Aglietta, M., & Sangiolo, D. (2014) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s38428 · Cited by 27
Alginate Containing Nanoarchitectonics for Improved Cancer Therapy
Giri, T. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-47347-7.00020-3 · Cited by 26
Current Approaches in Development of Immunotherapeutic Vaccines for Breast Cancer
Allahverdiyev, A., Tari, G., Bağırova, M., & Abamor, E. Ş. (2018) · Journal of Breast Cancer · doi:10.4048/jbc.2018.21.e47 · Cited by 25
Chitosan nano-formulation enhances stability and bactericidal activity of the lytic phage HK6
Temsaah, H. R., Abdelkader, K., Ahmed, A. E., Elgiddawy, N., Eldin, Z. E., Elshebrawy, H. A., Kasem, N. G., El-Gohary, F. A., & Azmy, A. F. (2025) · BMC Biotechnology · doi:10.1186/s12896-024-00934-6 · Cited by 24
Polymeric nanoparticles for DNA vaccine-based cancer immunotherapy: a review
Danaeifar, M., Negahdari, B., Eslam, H. M., Zare, H., Ghanaat, M., Koushali, S. S., & Malekshahi, Z. V. (2023) · Biotechnology Letters · doi:10.1007/s10529-023-03383-x · Cited by 29
The Use of Immunotherapy to Treat Metastatic Breast Cancer
Nicolini, A., Barak, V., Biava, P. M., Ferrari, P., Rossi, G., & Carpi, A. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180209124052 · Cited by 24
Engineered biomaterials for development of nucleic acid vaccines
Yang, H. J., Li, Y., Jin, S., Xu, J., Wang, P. C., Liang, X., & Zhang, X. (2015) · Biomaterials Research · doi:10.1186/s40824-014-0025-8 · Cited by 23
Wang, M., Yue, Y., Dong, C., Li, X., Xu, W., & Xiong, S. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00466-13 · Cited by 22
A new tandem peptide modified liposomal doxorubicin for tumor “ecological therapy”
Zhao, T., Zhou, H., Lei, L., Guo, C., Yang, Q., Gong, T., Sun, X., Song, X., Gong, T., & Zhang, Z. (2020) · Nanoscale · doi:10.1039/c9nr09585c · Cited by 21
Peng, H. C., Wang, J., Guo, F., Zhu, F.-F., Wen, Z.-J., Zhong, H., & Liang, D.-S. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111442 · Cited by 20
Bande, F., Arshad, S. S., Bejo, M. H., Kamba, A. S., & Omar, A. R. (2015) · Journal of Nanomaterials · doi:10.1155/2015/371529 · Cited by 20
Chen, H., Liu, X., Clayman, E. S., Shao, F., Xiao, M., Tian, X., Fu, W.-Y., Zhang, C., Ruan, B.-B., Zhou, P., et al. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12525 · Cited by 20
Self-citationDeniz, İ., García‐Vaquero, M., & İmamoğlu, E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-101023-5.00018-2 · Cited by 21
VLPs and particle strategies for cancer vaccines
Ungaro, F., Conte, C., Quaglia, F., Tornesello, M. L., Buonaguro, L., & Buonaguro, L. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.836909 · Cited by 18
Application of multifunctional nanomaterials in cancer vaccines (Review)
Fu, B., Huang, X., Deng, J., Gu, D., Mei, Q., Deng, M., Tang, S., & ⁄, M. L. (2018) · Oncology Reports · doi:10.3892/or.2018.6206 · Cited by 18
Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer
Navarro-Ocón, A., Blaya-Cánovas, J. L., López-Tejada, A., Blancas, I., Sanchez-Martin, R. M., Garrido, M. J., Griñán‐Lisón, C., Calahorra, J., Cara, F. E., Ruiz‐Cabello, F., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030505 · Cited by 17
Polymer-Based Nanoparticles as Modern Vaccine Delivery Systems
Lambricht, L., Peres, C. A., Florindo, H. F., Véronique Préat, A., & Vandermeulen, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-39981-4.00010-5 · Cited by 16
Nanometric Biopolymer Devices for Oral Delivery of Macromolecules with Clinical Significance
Maiti, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-52725-5.00006-x · Cited by 16
Single-dose in situ storage for intensifying anticancer efficacy via combinatorial strategy
Hou, L., Yan, Y., Tian, C., Huang, Q., Fu, X.-J., Zhang, Z., Zhang, H., Zhang, H., & Zhang, Z. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.014 · Cited by 16
Lin, S., Deng, F., Huang, P., Li, L., Wang, L., Li, Q. F., Chen, L., Chen, H., & Nan, K. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00736d · Cited by 15
Yazdani, M., Jaafari, M. R., Verdi, J., Alani, B., Noureddini, M., & Badiee, A. (2020) · Immunotherapy · doi:10.2217/imt-2019-0173 · Cited by 14
Luo, M., Li, Q., Wang, D., Ge, C., Wang, J., Nan, K., & Lin, S. (2018) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-018-6149-y · Cited by 14
Self-citationPolysaccharide-Based Nanocarriers for Drug Delivery
Teijeiro, C., McGlone, A., Csaba, N., García-Fuentes, M., & Alonso, M. J. (2014) · Frontiers in nanobiomedical research · doi:10.1142/9789814520652_0007 · Cited by 12
Therapeutic effects of chitosan in veterinary dermatology: A systematic review of the literature
Maldonado-Cabrera, B., Sánchez‐Machado, D. I., López‐Cervántes, J., Osuna-Chávez, R. F., Escárcega-Galaz, A. A., Robles‐Zepeda, R. E., & Sanches-Silva, A. T. (2021) · Preventive Veterinary Medicine · doi:10.1016/j.prevetmed.2021.105325 · Cited by 12
Chitosan Nanoparticles: An Emerging Weapon against the Cancer
Potdar, P. (2016) · MOJ Cell Science & Report · doi:10.15406/mojcsr.2016.03.00049 · Cited by 10
Chitosan Nanoparticles: An Overview on Preparation, Characterization and Biomedical Applications
Mesa, A., Mythatha, G. S. S., Lodi, R. S., Ravuri, S. K., & Balli, R. (2021) · Environmental and microbial biotechnology · doi:10.1007/978-981-15-9916-3_17 · Cited by 10
Biopolymer‐based Carriers for DNA Vaccine Design
Franck, C. O., Fanslau, L., Bistrović, A., Tyagi, P., & Fruk, L. (2020) · Angewandte Chemie · doi:10.1002/ange.202010282 · Cited by 10
Martino, A. D., Özaltın, K., Trusova, M. E., Постников, П. С., & Sedlařík, V. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.01.003 · Cited by 9
Alginic Acid: a Potential Biopolymer from Brown Algae
(2020) · Materials International · doi:10.33263/materials23.433438 · Cited by 9
New Era on Combining Both Imaging and Drug Delivery to Treat Cancer
Siafaka, P. I., Çağlar, E. Ş., Gündoğdu, E., & Okur, N. Ü. (2022) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023666220617152334 · Cited by 8
An Ocean of Possibilities: A Review of Marine Organisms as Sources of Nanoparticles for Cancer Care
Püsküllüoğlu, M., & Michalak, I. (2022) · Nanomedicine · doi:10.2217/nnm-2022-0206 · Cited by 8
Zhao, T., Li, Z., Guo, Z., Wang, A., Liu, Z., Zhao, Q. S., Li, Y., McKenzie, E. A., & Diao, A. (2018) · Protein Expression and Purification · doi:10.1016/j.pep.2018.05.003 · Cited by 8
Self-citationGovindan, P., Pitchaikani, S., Kandasamy, S., Rajan, M., Shakila, H., Eed, E. M., Elfasakhany, A., & Pugazhendhi, A. (2021) · Environmental Research · doi:10.1016/j.envres.2021.111699 · Cited by 8
RetractedNanoparticle Technology for Respiratory Tract Mucosal Vaccine Delivery
Johnson, L. M., Mecham, J. B., Quinn, F. D., & Hickey, A. J. (2019) · KONA Powder and Particle Journal · doi:10.14356/kona.2020013 · Cited by 8
Alginate in Gene and Vaccine Delivery
Abdelhamid, H. N. (2023) · Springer eBooks · doi:10.1007/978-981-19-6937-9_14 · Cited by 7
Nanotechnology Approaches for Cancer Immunotherapy and Immunomodulation
de la Fuente, M., Langer, R., & Alonso, M. J. (2014) · Advances in delivery science and technology · doi:10.1007/978-3-319-08084-0_8 · Cited by 7
Extraction, structural properties, and applications of alginic acid
Hassabo, A. G., & Mohamed, A. L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99468-2.00023-1 · Cited by 6
PRAKASH, D., Arora, V., & Dewangan, H. K. (2023) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2023v15i5.48183 · Cited by 6
Peyer’s Patch: Targeted Drug Delivery for Therapeutics Benefits
Patel, R. P., Shah, P., Barve, K. H., Patel, N. A., & Gandhi, J. (2019) · Springer eBooks · doi:10.1007/978-981-13-3642-3_5 · Cited by 6
Interaction of green nanoparticles with cells and organs
Rahim, M., Rizvi, S. M. D., Iram, S., Khan, S., Bagga, P., & Khan, M. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813661-4.00005-5 · Cited by 6
Blades and barriers: Oral vaccines for conquering cancers and warding off infectious diseases
Yang, K., Liu, J., Zhao, Y., Xu, H., Zu, M., Li, B., Shi, X., Reis, R. L., Kundu, S. C., & Xiao, B. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.05.038 · Cited by 5
Das, S., Pan, R., Dey, R., & Ghosh, M. (2022) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v12i1-s.5345 · Cited by 5
In vitro evaluation of polyethylene glycol based microparticles containing azithromycin
Shunmugaperumal, T., Kumar, V., Sharma, D., & Thakur, A. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0187-2 · Cited by 5
Chitosan-Based Mucosal Nanovaccines
Rosales‐Mendoza, S., & González‐Ortega, O. (2019) · Springer eBooks · doi:10.1007/978-3-030-31668-6_8 · Cited by 5
Marine Algal‐derived Pharmaceuticals
Cheriyamundath, S., & Vavilala, S. L. (2020) · Wiley eBooks · doi:10.1002/9781119143802.ch120 · Cited by 5
Farzi, G., & Gheysipour, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824345-9.00010-6 · Cited by 4
Recent Trends and Strategies for Targeting M – Cells via Oral Vaccine against Hepatitis B: A Review
Saraf, S. K. (2019) · International Journal of Cell Science & Molecular Biology · doi:10.19080/ijcsmb.2019.05.555671 · Cited by 4
Advanced drug delivery systems in breast cancer
Singh, S., Singh, P., Mishra, N., Maurya, P., Singh, N., Nisha, R., & Saraf, S. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85503-7.00028-6 · Cited by 4
Shunmugaperumal, T., Sharma, D., Thakur, A., & Vinaykumar (2013) · Interventional Medicine and Applied Science · doi:10.1556/imas.5.2013.4.5 · Cited by 4
Nanotechnology for RNA and DNA Delivery in Cancer Therapeutics
Safo, K. K., Ogoe, M., George, N., Gupta, A., Janiyani, K., Singh, H., Babu, K. G., & Pandya, S. R. (2025) · Series in bioengineering · doi:10.1007/978-981-95-0457-2_7 · Cited by 3
TRIVALENT ION CROSS-LINKED AND ACETALATED GELLAN GUM MICROSPHERES OF GLIMEPIRIDE
Das, S., & Dey, R. (2020) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2020.v13i5.37229 · Cited by 3
Metadata
- Authors
- Liu, Z., Lv, D., Liu, S., Gong, J., Wang, D., Xiong, M., Chen, X., Xiang, R., & Tan, X.
- Affiliations
- Nankai University (CN)
- Tianjin University (CN)
- Corresponding author
- Tan, Xiaoyue
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-04-05
- Volume
- 8
- Issue
- 4
- Pages
- e60190
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3618226
- OpenAlex
- W1993169857
- Cited by
- 108
- References
- 37
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 8 · 2022: 8 · 2021: 13 · 2020: 9 · 2019: 7 · 2018: 9 · 2017: 7 · 2016: 13 · 2015: 9 · 2014: 11 · 2013: 7
- FWCI
- 8.02
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- National Natural Science Foundation of China (81273331, 2013CB967201, 973 Program, 81270774)
- National Key Research and Development Program of China (2013CB967201)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- legumain, DNA vaccine, breast cancer, chitosan nanoparticles, oral vaccine delivery, attenuated Salmonella typhimurium, 4T1 breast cancer, cytotoxic T lymphocytes, Peyer's patches, nanoparticle aggregation
- MeSH terms
- Asparaginyl Endopeptidase, Alginates, Animals, Antigen-Presenting Cells, Biological Transport, Cysteine Endopeptidases, Drug Carriers, Female, Gastric Mucosa, Hexuronic Acids, Hydrogen-Ion Concentration, Macrophages, Mammary Neoplasms, Experimental, Mice, Inbred BALB C, Peyer's Patches, T-Lymphocytes, Vaccines, DNA, Cancer Vaccines, Glucuronic Acid, Chitosan, Cell Proliferation, Mice, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
